849
Views
34
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Limited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients

, , , &
Pages 716-724 | Received 15 Apr 2014, Accepted 27 May 2014, Published online: 06 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Katsuhiro Miura, Hiromichi Takahashi, Masaru Nakagawa, Takashi Hamada, Yoshihito Uchino, Kazuhide Iizuka, Shimon Ohtake, Noriyoshi Iriyama, Yoshihiro Hatta & Hideki Nakamura. (2022) Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma. Expert Review of Anticancer Therapy 22:6, pages 583-595.
Read now
Jorge A. Florindez, Juan Pablo Alderuccio, Isildinha M. Reis & Izidore S. Lossos. (2021) Primary thyroid lymphoma: survival analysis of SEER database (1995–2016). Leukemia & Lymphoma 62:11, pages 2796-2799.
Read now
Parastoo B. Dahi, Craig H. Moskowitz, Sergio A. Giralt & Hillard M. Lazarus. (2019) Novel agents may positively impact chemotherapy and transplantation in subsets of diffuse large B-cell lymphoma. Expert Review of Hematology 12:6, pages 407-418.
Read now
Yolanda D. Tseng, Andrea K. Ng & Andrew Wirth. (2019) New tools of the trade: parsing out the role of radiotherapy for early-stage diffuse large B-cell lymphoma. Leukemia & Lymphoma 60:4, pages 861-863.
Read now
Annalisa Chiappella, Alessia Castellino, Maura Nicolosi, Elisa Santambrogio & Umberto Vitolo. (2017) Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives. Expert Review of Hematology 10:4, pages 289-297.
Read now
Christopher R. Flowers, Jonathon B. Cohen & Mohammad K. Khan. (2015) Rebirth of radiotherapy for elderly patients with diffuse large B-cell lymphoma in the rituximab era. Leukemia & Lymphoma 56:3, pages 557-558.
Read now

Articles from other publishers (27)

Fabiola N. Velazquez, Jeffrey L. Stith, Leiqing Zhang, Amira M. Allam, John Haley, Lina M. Obeid, Ashley J. Snider & Yusuf A. Hannun. (2023) Targeting sphingosine kinase 1 in p53KO thymic lymphoma . The FASEB Journal 37:11.
Crossref
Josep Gumà, Natalia Palazón-Carrión, Antonio Rueda-Domínguez, Silvia Sequero, Virginia Calvo, Ramón García-Arroyo, José Gómez-Codina, Marta Llanos, Natividad Martínez-Banaclocha & Mariano Provencio. (2023) SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022). Clinical and Translational Oncology 25:9, pages 2749-2758.
Crossref
Joel Wight, Nada Hamad, Belinda A. Campbell, Matthew Ku, Kenneth Lee, Hannah Rose, Tasman Armytage, Maya Latimer, Hui‐Peng Lee, Sze‐Ting Lee, Michael Dickinson, Richard Khor & Emma Verner. (2022) Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal 52:9, pages 1609-1623.
Crossref
Kana Miyazaki. (2022) Management of elderly patients with malignant lymphoma. Japanese Journal of Clinical Oncology 52:7, pages 690-699.
Crossref
Eliza A. Hawkes, Allison Barraclough & Laurie H. Sehn. (2022) Limited-stage diffuse large B-cell lymphoma. Blood 139:6, pages 822-834.
Crossref
Elizabeth H Phillips, Rohan Iype & Andrew Wirth. (2021) PET-guided treatment for personalised therapy of Hodgkin lymphoma and aggressive non-Hodgkin lymphoma. The British Journal of Radiology 94:1127.
Crossref
Xiao‐Yin Zhang, Graham P. Collins, David J. Cutter & Toby A. Eyre. (2021) Limited‐stage diffuse large B‐cell lymphoma: current management and challenges. British Journal of Haematology 194:3, pages 508-517.
Crossref
Mengyang Di, Scott F Huntington & Adam J. Olszewski. (2021) Challenges and Opportunities in the Management of Diffuse Large B-Cell Lymphoma in Older Patients. The Oncologist 26:2, pages 120-132.
Crossref
Mary-Elizabeth M. Percival, Ryan C. Lynch, Anna B. Halpern, Mazyar Shadman, Ryan D. Cassaday, Chaitra Ujjani, Andrei Shustov, Yolanda D. Tseng, Catherine Liu, Steven Pergam, Edward N. Libby, Bart L. Scott, Stephen D. Smith, Damian J. Green, Ajay K. Gopal & Andrew J. Cowan. (2020) Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle Strategy. JCO Oncology Practice 16:9, pages 571-578.
Crossref
Brandon S. Imber & Joachim Yahalom. (2020) Radiotherapy for Non-Hodgkin Lymphomas. The Cancer Journal 26:3, pages 217-230.
Crossref
Adam J. Olszewski, James N. Butera, John L. Reagan & Jorge J. Castillo. (2020) Outcomes of bendamustine‐ or cyclophosphamide‐based first‐line chemotherapy in older patients with indolent B‐cell lymphoma. American Journal of Hematology 95:4, pages 354-361.
Crossref
Yolanda D. Tseng & Andrea K. Ng. (2020) Hematologic Malignancies. Hematology/Oncology Clinics of North America 34:1, pages 127-142.
Crossref
Vicki A. Morrison. 2020. Geriatric Oncology. Geriatric Oncology 583 612 .
Allison BarracloughMusa AlzahraniMarianne Schmidt EttrupMark Bishton, Chris van VlietPedro Farinha, Clare Gould, Simone BirchLaurie H. SehnVishakha SovaniMitchell Steven WardBradley AugustsonJorne BicclerJoseph M. ConnorsDavid W. ScottMaher K. Gandhi, Kerry J. SavageTarec El-Galaly, Diego Villa & Chan Yoon Cheah. (2019) COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study. Blood Advances 3:13, pages 2013-2021.
Crossref
Yasemin Bolukbasi, Duygu Sezen, Yucel Saglam & Ugur Selek. 2019. Radiation Oncology. Radiation Oncology 455 500 .
Alden A. Moccia & Catherine Thieblemont. (2018) Curing diffuse large B-cell lymphomas in elderly patients. European Journal of Internal Medicine 58, pages 14-21.
Crossref
Marcel Nijland, Karin Boslooper, Gustaaf van Imhoff, Robbie Kibbelaar, Peter Joosten, Huib Storm, Eric N. van Roon, Arjan Diepstra, Hanneke C. Kluin-Nelemans & Mels Hoogendoorn. (2018) Relapse in stage I(E) diffuse large B-cell lymphoma. Hematological Oncology 36:2, pages 416-421.
Crossref
Anna K. Paulsson & Adam Garsa. 2018. Handbook of Evidence-Based Radiation Oncology. Handbook of Evidence-Based Radiation Oncology 757 768 .
Vicki A. Morrison. 2018. Geriatric Oncology. Geriatric Oncology 1 31 .
Chelsea C. Pinnix, Therese Y. Andraos, Bouthaina Dabaja, Sarah Milgrom, Grace Smith, Dai Chihara, Andrea Ng, Luis E. Fayad, Yasuhiro Oki, Sattva Neelapu, Jason Westin, M. Alma Rodriguez & Loretta J. Nastoupil. (2017) Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions. Advances in Radiation Oncology 2:3, pages 370-380.
Crossref
Eva Giné & Laurie H. Sehn. (2016) Diffuse Large B-Cell Lymphoma. Hematology/Oncology Clinics of North America 30:6, pages 1179-1194.
Crossref
C. Demoor-Goldschmidt, P. Agape, I. Barillot & M.A. Mahé. (2016) Radiothérapie des lymphomes malins non hodgkiniens ganglionnaires folliculaires et diffus de stade limité. Cancer/Radiothérapie 20:6-7, pages 530-534.
Crossref
Deborah M. StephensHongli LiMichael L. LeBlancSoham D. PuvvadaDaniel PerskyJonathan W. FriedbergSonali M. Smith. (2016) Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736. Journal of Clinical Oncology 34:25, pages 2997-3004.
Crossref
Andrea K. Ng, Bouthaina Shbib Dabaja, Richard T. Hoppe, Timothy Illidge & Joachim Yahalom. (2016) Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era. Journal of Clinical Oncology 34:13, pages 1443-1447.
Crossref
Adam J. Olszewski, Jaleh Falah & Jorge J. Castillo. (2016) Survival Claims From Observational Data on Cancer Therapy. Journal of Clinical Oncology 34:12, pages 1425-1427.
Crossref
Anita Kumar, Matthew A. Lunning, Zhigang Zhang, Jocelyn C. Migliacci, Craig H. Moskowitz & Andrew D. Zelenetz. (2015) Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era. British Journal of Haematology 171:5, pages 776-783.
Crossref
Jessica N. Williams, Jean L. Koff & Christopher R. Flowers. (2015) Reply to treatment decisions and outcome in very elderly patients with diffuse large B-cell lymphoma. Cancer 121:20, pages 3748-3748.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.